Finance

Beta
Lists
QCORE:STO
Qlucore publ AB
SEK 0.45
0.00%
(0.00) 1D
Jun 3, 12:43:34 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for QCORE...
Mkt. cap
19.39M
Avg. vol.
55.79K
Volume
0.00
52-wk high
SEK 1.76
52-wk low
SEK 0.25
EPS
-SEK 2.57
Shares outstanding
42.90M
No. of employees
15
Mkt. cap
19.39M
Avg. vol.
55.79K
Volume
0.00
52-wk high
SEK 1.76
52-wk low
SEK 0.25
EPS
-SEK 2.57
Shares outstanding
42.90M
No. of employees
15
News stories
From sources across the web
Profile
Qlucore is a Swedish Bioinformatics software company founded in the year 2007. It started as a collaborative research project at Lund University, Sweden, supported by researchers at the Departments of Mathematics and Clinical Genetics. The objective was to address the vast amount of high-dimensional data generated with microarray gene expression analysis. To this end, it was imperative to have an interactive scientific software tool necessary for the conceptualize ideas emanating from the research collaborations. Since then, a new version of the software has been released approximately every nine months. In 2017, Qlucore took a major step in the technology by adding the NGS module including a dynamic and fast Genome browser to enable analysis of data being generated with Next Generation Sequencing technologies. Qlucore Omics Explorer is a visualisation based software program that provides for the exploration and visualization of big data. This enables researchers to analyze and explore large data sets on a regular PC or Mac. Qlucore Omics Explorer customers are mainly from the Life Science, Plant, Food, and Biotech industries and from matching academic research areas. Wikipedia
About Qlucore publ AB
CEO-
Employees15
FoundedJan 15, 2007
Headquarters-
SectorHealth care
Websiteqlucore.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
1.81M
2.22M
3.71M
4.98M
Cost of goods sold
6.15M
3.79M
4.26M
3.70M
Cost of revenue
6.15M
3.79M
4.26M
3.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.58M
2.11M
5.17M
3.04M
Operating expense
2.22M
21.56M
2.69M
4.73M
Total operating expenses
8.37M
25.35M
6.95M
8.43M
Operating income
-6.55M
-23.14M
-3.24M
-3.45M
Other non operating income
1.00K
1.00K
-
1.00K
EBT including unusual items
-6.61M
-23.21M
-3.31M
-3.38M
EBT excluding unusual items
-6.61M
-23.21M
-3.31M
-3.38M
Income tax expense
5.00K
5.00K
5.00K
-2.00K
Effective tax rate
-0.08%
-0.02%
-0.15%
0.06%
Other operating expenses
-2.53M
17.32M
-4.15M
83.00K
Net income
-6.62M
-23.21M
-3.31M
-3.38M
Net profit margin
-365.09%
-1,047.47%
-89.20%
-67.88%
Earnings per share
-
-
-
-
Interest and investment income
1.00K
1.00K
8.00K
42.00K
Interest expense
-63.00K
-74.00K
-76.00K
19.00K
Net interest expenses
-62.00K
-73.00K
-68.00K
61.00K
Depreciation and amortization charges
2.17M
2.13M
1.67M
1.61M
EBITDA
-4.38M
-21.00M
-1.57M
-1.84M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer